• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.61 -$0.01 (-0.07%)

REAL-TIME: Last trade at

Human Genome Sciences

NASDAQ:HGSI

Jump to this page for:

Related Resources

Human Genome should still see a higher bid, says RW Baird

5/25/2012 by Theflyonthewall.com

Analysts' Actions: ARO, DUK, PPG

5/24/2012 by TheStreet.com

A Forward Look, the Year Ahead - Featured Research on Jazz Pharmaceuticals and Human Genome Sciences

5/24/2012 by Marketwire

Top Analyst Upgrades & Downgrades (ADI, ARMH, AGO, BHI, DF, DELL, DUK, EV, EXPR, HPQ, HGSI, IRDM, MET, NOV, OCZ, RSH, RA)

5/24/2012 by 24/7 Wall Street

BMO Capital Downgrades Human Genome Sciences (HGSI) to Market Perform

5/24/2012 by StreetInsider.com

Human Genome downgraded to Market Perform from Outperform at BMO Capital

5/24/2012 by Theflyonthewall.com

GlaxoSmithKline won’t swallow Human Genome Sciences’ poison pill

5/23/2012 by Philadelphia Business Journal - Philadelphia PA

GlaxoSmithKline Amends Offer In Response To Human Genome Poison Pill

5/23/2012 by RTTNews

Glaxo Amends Its $2.59 Billion Bid for Human Genome Sciences

5/23/2012 by DealBook - The New York Times

Human Genome Sciences Rejects GlaxoSmithKline's $2.6 Billion Offer

5/21/2012 by BioPharm International

GSK statement on tender offer to acquire Human Genome Sciences

5/19/2012 by Pharmaceutical Processing

Will Anthera's PEARL Shine Or Sink?

5/19/2012 by RTTNews

HGSI fights GSK bid with 'poison pill'

5/17/2012 by FT.com

GlaxoSmithKline To Proceed With Tender Offer To Acquire Human Genome - Update

5/17/2012 by RTTNews

UPDATE: Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo

5/17/2012 by NASDAQ

Human Genome Sciences rejects GSK takeover bid

5/17/2012 by Triangle Business Journal - Raleigh NC

Human Genome Sciences adopts stockholder rights plan

5/17/2012 by Baltimore Business Journal - Baltimore MD

Bankia Customers Withdraw 1B Euros in One Week: Hot Trends

5/17/2012 by TheStreet.com

Human Genome Sciences Adopts Poison Pill to Thwart Glaxo Takeover

5/17/2012 by DealBook - The New York Times

Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo

5/17/2012 by NASDAQ

Human Genome says in talks with a number of other parties

5/17/2012 by Theflyonthewall.com

Human Genome Sciences (HGSI) Unanimously Rejects GlaxoSmithKline (GSK) Offer

5/17/2012 by StreetInsider.com

Human Genome board determines GlaxoSmithKline offer is inadequate

5/17/2012 by Theflyonthewall.com

Human Genome Sciences Announces Adoption of Short-Term Stockholder Rights Plan

5/17/2012 by Business Wire

Human Genome Sciences Board of Directors Unanimously Determines GlaxoSmithKline Unsolicited Tender Offer is Inadequate and Not in the Best Interests of Stockholders

5/17/2012 by Business Wire

Stocks with implied volatility movement; MCP HGSI

5/17/2012 by Theflyonthewall.com

05.15.12 -- GSK Offers $2.6B For Human Genome Sciences

5/15/2012 by Pharmaceutical Online

GlaxoSmithKline's 4.8% Yield Makes It Attractive With Or Without Human Genome Takeover

5/14/2012 by Seeking Alpha

GlaxoSmithKline Moves Forward with $2.6 Billion Offer for Human Genome Sciences

5/14/2012 by BioPharm International

A Health Care Fortnight for the Record Books

5/14/2012 by TheStreet.com

GSK to commence tender offer to acquire Human Genome Sciences for US $13.00 per share in cash

5/14/2012 by Pharmaceutical Processing

GSK commences tender offer of Human Genome Sciences

5/11/2012 by Drug Store News

Witty targets HGS with first hostile bid

5/11/2012 by FT.com

Stocks with call strike movement; NTAP HGSI

5/10/2012 by Theflyonthewall.com

Key Short Interest Changes in Cult Stocks & Controversial Stocks (ALU, STD, BAC, BKS, DNDN, DMND, FSLR, GMCR, GRPN, HGSI, LNKD, NFLX, RSH, RIMM, SIRI)

5/10/2012 by 24/7 Wall Street

Pre-market Movers For May 10 (CSCO, KSS, AVP, BECN, HGSI, ARNA)

5/10/2012 by RTTNews

Human Genome takeover bid could go higher, says RW Baird

5/10/2012 by Theflyonthewall.com

Top Analyst Upgrades & Downgrades (ARMH, BIG, CHKM, CSCO, CPWM, DLB, HGSI, JDSU, LINE, MMM, NOV, ORCL, RGP, TPX, TLLP, TEVA, VRTX)

5/10/2012 by 24/7 Wall Street

"Lupus Out Loud" Movement Inspires Patients to Speak Out About Their Symptoms

5/10/2012 by PR Newswire

Leerink Swann Downgrades Human Genome Sciences (HGSI) to Market Perform; Limited Visibility

5/10/2012 by StreetInsider.com
See More Articles...